X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 16/Feb 17:41

Chronic inflammation shapes cancer progression and immunotherapy response

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

Articles similaires

New biomarker predicts prognosis and treatment response in colorectal cancer

news.medical.net - 15/Apr 02:50

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in...

Sorry! Image not available at this time

New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer

drugs.com - 19/Apr 10:30

SUNDAY, April 19, 2026 — Immunotherapy has largely failed as a treatment for cancer of the pancreas, and researchers have zeroed in on a key...

How inflammation may prime the gut for cancer

oncologynews.com.au - 11/Apr 06:49

Chronic inflammation can raise a person’s risk of cancer, and a new study reveals key details about how that might happen in the gut and points to...

How inflammation may prime the gut for cancer

oncologynews.com.au - 11/Apr 06:49

Chronic inflammation can raise a person’s risk of cancer, and a new study reveals key details about how that might happen in the gut and points to...

Sorry! Image not available at this time

Doctors may have found an effective weapon against a genetic driver of lung cancer, early ...

wn.com - 19/Apr 19:34

Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who had few other options....

Sorry! Image not available at this time

Doctors may have found an effective weapon against a genetic driver of lung cancer, early ...

wn.com - 19/Apr 19:34

Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who had few other options....

Age shapes melanoma progression and immune response

news.medical.net - 17/Apr 15:23

Cancer risk increases with age and is often more aggressive and difficult to treat in older adults. However, fewer than 10% of mouse studies use aged...

Common metabolic enzyme could predict cancer immunotherapy benefits

oncologynews.com.au - 11/Apr 09:57

Immunotherapies have transformed cancer treatment by helping the immune system recognise and attack tumours. They work for only about 20% of patients,...

Common metabolic enzyme could predict cancer immunotherapy benefits

oncologynews.com.au - 11/Apr 09:57

Immunotherapies have transformed cancer treatment by helping the immune system recognise and attack tumours. They work for only about 20% of patients,...

Sorry! Image not available at this time

Chronic Hand Eczema Market Forecast 2034: Explore Next-Gen Treatments, Regulatory Milestones, and Competitive Intelligence | DelveInsight

wn.com - 07/Apr 23:59

"Chronic Hand Eczema Market" Key players in the Chronic Hand Eczema market include Basilea Pharmaceutica, Stiefel Laboratories, LEO Pharma, Asana...